EE249 Cost-Effectiveness of Etrasimod, Ozanimod, and Adalimumab Compared to Infliximab in Treatment-Naive Patients With Moderate to Severe Ulcerative Colitis
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.633
https://www.valueinhealthjournal.com/article/S1098-3015(25)03190-0/fulltext
Title :
EE249 Cost-Effectiveness of Etrasimod, Ozanimod, and Adalimumab Compared to Infliximab in Treatment-Naive Patients With Moderate to Severe Ulcerative Colitis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03190-0&doi=10.1016/j.jval.2025.09.633
First page :
Section Title :
Open access? :
No
Section Order :
10218